Immatics N.V. (IMTX) vs Vor Biopharma Inc. (VOR)
- Immatics N.V. IMTX 6.72 −5.88%
- Vor Biopharma Inc. VOR 18.03 −6.77%
Immatics N.V. and Vor Biopharma Inc. are both Biotechnology companies. Immatics N.V. and Vor Biopharma Inc. are of similar size ($1.1B and $1.1B). Vor Biopharma Inc. has the higher net margin (0.00% vs −489.4%) and the higher return on invested capital (0.00% vs −84.8%). Across the 13 metrics below, Vor Biopharma Inc. leads on 7 and Immatics N.V. on 6.
Valuation
Profitability
| Metric | IMTX | VOR | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (536.26%) | — | 0.00% |
| Net margin | (489.35%) | 0.00% | 0.00% |
| Free cash flow margin | (488.01%) | 0.00% | 0.00% |
| Return on equity | (48.53%) | (69.27%) | (56.36%) |
| Return on assets | (39.83%) | 0.00% | (48.04%) |
| Return on invested capital | (84.83%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack